BB-2516: Began U.K. tests

British Biotech plc (BBIOY), Oxford, U.K.
Product: Batimastat matrix metalloproteinase inhibitor
Indication: Malignant

Read the full 137 word article

How to gain access

Continue reading with a
two-week free trial.